Recent Updates
Recently added Catalysts
RARE

Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR

Friday, September 9, 2022 1 min read
Key Takeaway: Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR

Full Press Release Details

Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR.
Tags: RARE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Sep 9, 2022